Literature DB >> 31805501

Polymerase iota - an odd sibling among Y family polymerases.

Justyna McIntyre1.   

Abstract

It has been two decades since the discovery of the most mutagenic human DNA polymerase, polymerase iota (Polι). Since then, the biochemical activity of this translesion synthesis (TLS) enzyme has been extensively explored, mostly through in vitro experiments, with some insight into its cellular activity. Polι is one of four members of the Y-family of polymerases, which are the best characterized DNA damage-tolerant polymerases involved in TLS. Polι shares some common Y-family features, including low catalytic efficiency and processivity, high infidelity, the ability to bypass some DNA lesions, and a deficiency in 3'→5' exonucleolytic proofreading. However, Polι exhibits numerous properties unique among the Y-family enzymes. Polι has an unusual catalytic pocket structure and prefers Hoogsteen over Watson-Crick pairing, and its replication fidelity strongly depends on the template; further, it prefers Mn2+ ions rather than Mg2+ as catalytic activators. In addition to its polymerase activity, Polι possesses also 5'-deoxyribose phosphate (dRP) lyase activity, and its ability to participate in base excision repair has been shown. As a highly error-prone polymerase, its regulation is crucial and mostly involves posttranslational modifications and protein-protein interactions. The upregulation and downregulation of Polι are correlated with different types of cancer and suggestions regarding the possible function of this polymerase have emerged from studies of various cancer lines. Nonetheless, after twenty years of research, the biological function of Polι  certainly remains unresolved.
Copyright © 2019 The Author. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Y-family DNA polymerase; polymerase iota; translesion DNA synthesis

Year:  2019        PMID: 31805501     DOI: 10.1016/j.dnarep.2019.102753

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  7 in total

1.  Sequence context effects of replication of Fapy•dG in three mutational hot spot sequences of the p53 gene in human cells.

Authors:  Jan Henric T Bacurio; Haozhe Yang; Spandana Naldiga; Brent V Powell; Benjamin J Ryan; Bret D Freudenthal; Marc M Greenberg; Ashis K Basu
Journal:  DNA Repair (Amst)       Date:  2021-08-16

Review 2.  Mysterious and fascinating: DNA polymerase ɩ remains enigmatic 20 years after its discovery.

Authors:  Alexandra Vaisman; Roger Woodgate
Journal:  DNA Repair (Amst)       Date:  2020-09

Review 3.  Targeting translesion synthesis (TLS) to expose replication gaps, a unique cancer vulnerability.

Authors:  Sumeet Nayak; Jennifer A Calvo; Sharon B Cantor
Journal:  Expert Opin Ther Targets       Date:  2021-01-08       Impact factor: 6.902

4.  DNA polymerase ι compensates for Fanconi anemia pathway deficiency by countering DNA replication stress.

Authors:  Rui Wang; Walter F Lenoir; Chao Wang; Dan Su; Megan McLaughlin; Qianghua Hu; Xi Shen; Yanyan Tian; Naeh Klages-Mundt; Erica Lynn; Richard D Wood; Junjie Chen; Traver Hart; Lei Li
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 12.779

5.  Regulation of the abundance of Y-family polymerases in the cell cycle of budding yeast in response to DNA damage.

Authors:  Aleksandra Sobolewska; Agnieszka Halas; Michal Plachta; Justyna McIntyre; Ewa Sledziewska-Gojska
Journal:  Curr Genet       Date:  2020-02-19       Impact factor: 3.886

6.  Identification and Characterization of Thermostable Y-Family DNA Polymerases η, ι, κ and Rev1 From a Lower Eukaryote, Thermomyces lanuginosus.

Authors:  Alexandra Vaisman; John P McDonald; Mallory R Smith; Sender L Aspelund; Thomas C Evans; Roger Woodgate
Journal:  Front Mol Biosci       Date:  2021-11-03

7.  Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β.

Authors:  Shelby C Yuhas; Ananya Majumdar; Marc M Greenberg
Journal:  Chembiochem       Date:  2021-07-08       Impact factor: 3.164

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.